Nalbuphine extended release (ER) significantly reduces cough frequency and severity in patients with idiopathic pulmonary fibrosis (IPF), especially at higher doses, compared with placebo. The trial ...

Researchers have improved the ability of wearable health devices to accurately detect when a patient is coughing, making it easier to monitor chronic health conditions and predict health risks such as ...

Aldeyra Therapeutics Inc (NASDAQ:ALDX) announced top-line results from the Phase 2 clinical trial of ADX‑629, an investigational new drug administered orally to patients with chronic cough. The ...

Next time you're coughing, reach for a soothing cup of hot tea. While drinking hot tea of any kind can be helpful when you have a cough, simply because it’s hydrating, the steam can help open your ...

Smoking cannabis may increase the risk of respiratory disease such as chronic bronchitis, but quitting is likely to reduce the symptoms. It is unknown at this time whether cannabis use is linked to ...

Please provide your email address to receive an email when new articles are posted on . Camlipixant is a P2X3 antagonist. Studied patients had a baseline awake cough frequency of at least 25 coughs ...

Please provide your email address to receive an email when new articles are posted on . Gefapixant 45 mg twice daily resulted in clinically important reductions in cough frequency compared with ...

Cough imposed a substantial symptom burden in patients with hypersensitivity pneumonitis (HP). Corticosteroid therapy over 3 months was tied to reduced patient-reported cough severity and improved ...

Chronic cough affects some 80% of patients with idiopathic pulmonary fibrosis (IPF) and most patients consider it to be one of the most distressing IPF symptoms. In an early phase trial, the ...